Jun‐ichi Maeyama

876 total citations
33 papers, 722 citations indexed

About

Jun‐ichi Maeyama is a scholar working on Immunology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Jun‐ichi Maeyama has authored 33 papers receiving a total of 722 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Immunology, 10 papers in Infectious Diseases and 10 papers in Epidemiology. Recurrent topics in Jun‐ichi Maeyama's work include Immune Response and Inflammation (13 papers), Immunotherapy and Immune Responses (6 papers) and Clostridium difficile and Clostridium perfringens research (5 papers). Jun‐ichi Maeyama is often cited by papers focused on Immune Response and Inflammation (13 papers), Immunotherapy and Immune Responses (6 papers) and Clostridium difficile and Clostridium perfringens research (5 papers). Jun‐ichi Maeyama collaborates with scholars based in Japan, United States and Armenia. Jun‐ichi Maeyama's co-authors include Norihisa Goto, Shinobu Yoshihara, Masanori Isaka, Kunio Ohkuma, Kunio Tochikubo, Yoko Yasuda, Tooru Taniguchi, Keiko Matano, Sumiko Iho and Satoshi Kozuka and has published in prestigious journals such as PLoS ONE, Infection and Immunity and Vaccine.

In The Last Decade

Jun‐ichi Maeyama

33 papers receiving 706 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jun‐ichi Maeyama Japan	17	372	220	210	149	89	33	722
Yukari Hagiwara Japan	15	477 1.3×	158 0.7×	363 1.7×	192 1.3×	113 1.3×	17	862
Toshiya Koga United States	12	477 1.3×	150 0.7×	145 0.7×	121 0.8×	93 1.0×	18	825
Sae‐Hae Kim South Korea	17	411 1.1×	315 1.4×	111 0.5×	290 1.9×	49 0.6×	37	926
Teena Mohan India	17	431 1.2×	321 1.5×	361 1.7×	227 1.5×	18 0.2×	26	954
Rodolfo Pastelin‐Palacios Mexico	13	222 0.6×	156 0.7×	111 0.5×	222 1.5×	73 0.8×	35	655
Fadi Saadé Australia	9	306 0.8×	252 1.1×	246 1.2×	222 1.5×	21 0.2×	13	779
Chander Kanta Gupta Canada	8	243 0.7×	144 0.7×	145 0.7×	105 0.7×	23 0.3×	17	601
Luis Garcı́a Cuba	14	169 0.5×	174 0.8×	161 0.8×	95 0.6×	244 2.7×	35	653
Masanori Isaka Japan	18	237 0.6×	151 0.7×	204 1.0×	380 2.6×	137 1.5×	48	826
John B. Johnson United States	15	266 0.7×	156 0.7×	210 1.0×	161 1.1×	21 0.2×	31	731

Countries citing papers authored by Jun‐ichi Maeyama

Since Specialization

Citations

This map shows the geographic impact of Jun‐ichi Maeyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun‐ichi Maeyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun‐ichi Maeyama more than expected).

Fields of papers citing papers by Jun‐ichi Maeyama

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jun‐ichi Maeyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun‐ichi Maeyama. The network helps show where Jun‐ichi Maeyama may publish in the future.

Co-authorship network of co-authors of Jun‐ichi Maeyama

This figure shows the co-authorship network connecting the top 25 collaborators of Jun‐ichi Maeyama. A scholar is included among the top collaborators of Jun‐ichi Maeyama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jun‐ichi Maeyama. Jun‐ichi Maeyama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sasaki, Eita, Hideki Asanuma, Haruka Momose, et al.. (2025). Calboxyvinyl polymer adjuvant enhances respiratory IgA responses through mucosal and systemic administration. npj Vaccines. 10(1). 28–28. 1 indexed citations

Suzuki, Fumiko, Jun‐ichi Maeyama, Satomi Horiguchi, et al.. (2023). Effect of cigarette smoke on mucosal vaccine response with activation of plasmacytoid dendritic cells: The outcomes of in vivo and in vitro experiments. Vaccine. 41(8). 1447–1456. 5 indexed citations

Maeyama, Jun‐ichi, Hisakazu Takatsuka, Fumiko Suzuki, et al.. (2014). A Palindromic CpG-Containing Phosphodiester Oligodeoxynucleotide as a Mucosal Adjuvant Stimulates Plasmacytoid Dendritic Cell-Mediated TH1 Immunity. PLoS ONE. 9(2). e88846–e88846. 16 indexed citations

Ochiai, Masaki, Akihiko Yamamoto, Seishiro Naito, et al.. (2010). Applicability of bacterial endotoxins test to various blood products by the use of endotoxin-specific lysates. Biologicals. 38(6). 629–636. 8 indexed citations

Ichinohe, Takeshi, Akira Ainai, Tomoyuki Nakamura, et al.. (2009). Induction of cross‐protective immunity against influenza A virus H5N1 by an intranasal vaccine with extracts of mushroom mycelia. Journal of Medical Virology. 82(1). 128–137. 29 indexed citations

Hamaguchi, Isao, Jun‐ichi Imai, Haruka Momose, et al.. (2008). Application of quantitative gene expression analysis for pertussis vaccine safety control. Vaccine. 26(36). 4686–4696. 14 indexed citations

Isaka, Masanori, Yanqiu Zhao, Eri Nobusawa, et al.. (2008). Protective effect of nasal immunization of influenza virus hemagglutinin with recombinant cholera toxin B subunit as a mucosal adjuvant in mice. Microbiology and Immunology. 52(2). 55–63. 18 indexed citations

Mizukami, Takuo, Jun‐ichi Imai, Isao Hamaguchi, et al.. (2008). Application of DNA microarray technology to influenza A/Vietnam/1194/2004 (H5N1) vaccine safety evaluation. Vaccine. 26(18). 2270–2283. 30 indexed citations

Mizukami, Takuo, Atsuko Masumi, Haruka Momose, et al.. (2008). An improved abnormal toxicity test by using reference vaccine-specific body weight curves and histopathological data for monitoring vaccine quality and safety in Japan. Biologicals. 37(1). 8–17. 21 indexed citations

10.

Naito, Seishiro, Jun‐ichi Maeyama, Takuo Mizukami, et al.. (2007). Transcutaneous immunization by merely prolonging the duration of antigen presence on the skin of mice induces a potent antigen-specific antibody response even in the absence of an adjuvant. Vaccine. 25(52). 8762–8770. 25 indexed citations

11.

Hamaguchi, Isao, Junichi Imai, Haruka Momose, et al.. (2007). Two vaccine toxicity-related genes Agp and Hpx could prove useful for pertussis vaccine safety control. Vaccine. 25(17). 3355–3364. 17 indexed citations

12.

Maeyama, Jun‐ichi, Masanori Isaka, Yoko Yasuda, et al.. (2004). Effects of Recombinant Cholera Toxin B Subunit (rCTB) on Cellular Immune Responses: Enhancement of Delayed‐Type Hypersensitivity Following Intranasal Co‐Administration of Mycobacterium bovis‐BCG with rCTB. Microbiology and Immunology. 48(6). 457–463. 8 indexed citations

13.

Isaka, Masanori, Takako Komiya, Motohide Takahashi, et al.. (2004). Recombinant cholera toxin B subunit (rCTB) as a mucosal adjuvant enhances induction of diphtheria and tetanus antitoxin antibodies in mice by intranasal administration with diphtheria–pertussis–tetanus (DPT) combination vaccine. Vaccine. 22(23-24). 3061–3068. 20 indexed citations

14.

Yasuda, Yoko, Masanori Isaka, Tooru Taniguchi, et al.. (2003). Frequent nasal administrations of recombinant cholera toxin B subunit (rCTB)-containing tetanus and diphtheria toxoid vaccines induced antigen-specific serum and mucosal immune responses in the presence of anti-rCTB antibodies. Vaccine. 21(21-22). 2954–2963. 13 indexed citations

15.

Isaka, Masanori, Yoko Yasuda, Tooru Taniguchi, et al.. (2003). Mucosal and systemic antibody responses against an acellular pertussis vaccine in mice after intranasal co-administration with recombinant cholera toxin B subunit as an adjuvant. Vaccine. 21(11-12). 1165–1173. 23 indexed citations

16.

Isaka, Masanori, Yoko Yasuda, Masashi Mizokami, et al.. (2001). Mucosal immunization against hepatitis B virus by intranasal co-administration of recombinant hepatitis B surface antigen and recombinant cholera toxin B subunit as an adjuvant. Vaccine. 19(11-12). 1460–1466. 69 indexed citations

17.

Goto, Norihisa, Jun‐ichi Maeyama, Yoko Yasuda, et al.. (2000). Safety evaluation of recombinant cholera toxin B subunit produced by Bacillus brevis as a mucosal adjuvant. Vaccine. 18(20). 2164–2171. 34 indexed citations

18.

Isaka, Masanori, Yoko Yasuda, Satoshi Kozuka, et al.. (1999). Induction of systemic and mucosal antibody responses in mice immunized intranasally with aluminium-non-adsorbed diphtheria toxoid together with recombinant cholera toxin B subunit as an adjuvant. Vaccine. 18(7-8). 743–751. 46 indexed citations

19.

Goto, Norihisa, Hiroshi Kato, Jun‐ichi Maeyama, et al.. (1997). Local tissue irritating effects and adjuvant activities of calcium phosphate and aluminium hydroxide with different physical properties. Vaccine. 15(12-13). 1364–1371. 107 indexed citations

20.

Yamakawa, Yoshio, Tamotsu Omori‐Satoh, & Jun‐ichi Maeyama. (1991). Primary Structures of Cytotoxic Factors Isolated from Habu (Trimeresurus flavoviridis) Venom. The Journal of Biochemistry. 109(5). 667–669. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact